Imperial College London
Alternate

ProfessorPeterSever

Faculty of Medicine, National Heart & Lung Institute

Professor of Clinical Pharmacology & Therapeutics
 
 
 
//

Contact

 

+44 (0)20 7594 1099p.sever

 
 
//

Assistant

 

Mrs Yvonne Green +44 (0)20 7594 1100

 
//

Location

 

333ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Marston:2019,
author = {Marston, NA and Kamanu, FK and Nordio, F and Gurmu, Y and Roselli, C and Sever, PS and Pedersen, TR and Keech, AC and Wang, H and Pineda, AL and Giugliano, R and Lubitz, SA and Ellinor, PT and Sabatine, MS and Ruff, CT},
pages = {E977--E977},
publisher = {LIPPINCOTT WILLIAMS & WILKINS},
title = {Use of a Genetic Risk Score to Predict Coronary and Vascular Events and Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease From the FOURIER Trial},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000508228600034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Marston,NA
AU  - Kamanu,FK
AU  - Nordio,F
AU  - Gurmu,Y
AU  - Roselli,C
AU  - Sever,PS
AU  - Pedersen,TR
AU  - Keech,AC
AU  - Wang,H
AU  - Pineda,AL
AU  - Giugliano,R
AU  - Lubitz,SA
AU  - Ellinor,PT
AU  - Sabatine,MS
AU  - Ruff,CT
EP  - 977
PB  - LIPPINCOTT WILLIAMS & WILKINS
PY  - 2019///
SN  - 0009-7322
SP  - 977
TI  - Use of a Genetic Risk Score to Predict Coronary and Vascular Events and Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease From the FOURIER Trial
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000508228600034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download